Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-11FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
The FDA approved a supplemental application for pramipexole dihydrochloride submitted by ScieGen Pharmaceuticals Inc.
-
FDA approval · 2016-05-10FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark’s supplemental application for pramipexole dihydrochloride, authorizing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease [Phase 1]
This document reports the completion of a Phase 1 study in healthy male volunteers evaluating a new drug intended for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg) [Phase 1]
Phase 1 pharmacokinetic-pharmacodynamic interaction study assessing four single doses of BIA 3-202 with a single dose of Levodopa/Benserazid…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg) [Phase 1]
Phase 1 study assessing pharmacokinetic-pharmacodynamic interaction between four single doses of BIA 3-202 and a single dose of levodopa/car…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202 [Phase 1]
This document reports the completion of a Phase 1 study evaluating the safety, tolerability, and pharmacokinetic/pharmacodynamic profile of …
-
CLINICAL_TRIALS research · 2016-05-05Clinical Trial Update: Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease [NA]
Clinical trial investigates deep brain stimulation of the nucleus basalis of Meynert to treat cognitive deficits in Parkinson's disease; cur…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)
A completed clinical trial from Washington University School of Medicine investigating mood mapping in the subthalamic nucleus for Parkinson…
-
FDA approval · 2016-04-29FDA Approved: NUPLAZID — Original Application (Acadia Pharmaceuticals Inc.)
The FDA approved Nuplazid (pimavanserin tartrate) from Acadia Pharmaceuticals in its original NDA, for the treatment of hallucinations and d…
-
FDA approval · 2016-04-28FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited. The drug is indicated for the treatme…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Automated Telehealth Diagnostics for Remote Parkinson Monitoring [NA]
This clinical trial update reports completion of a study evaluating automated telehealth diagnostics for remote monitoring of Parkinson's di…
-
CLINICAL_TRIALS other · 2016-04-27Clinical Trial Update: Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison [NA]
A clinical trial update for a study comparing dysarthria in Parkinson's disease across language groups; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]
A Phase 2 study evaluating the efficacy and safety of eltoprazine HCl for levodopa-induced dyskinesia in Parkinson's disease; the update ind…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications [Phase 3]
Phase 3 study evaluating ABT-SLV187 as monotherapy in advanced Parkinson's disease with persistent motor complications; results were posted …
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's Disease [NA]
This document provides an update on an ongoing clinical trial evaluating the effects of a physical therapy program on behavior in patients w…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients [Phase 2]
Phase 2 trial assessing the efficacy and safety of AFQ056 to reduce L-dopa-induced dyskinesias in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults [NA]
A completed study evaluated a treadmill training program augmented by virtual reality to reduce fall risk in older adults, including partici…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: MENTAL PRACTICE IN MOTOR LEARNING OF BRUSHING AND PARKINSON DISEASE [NA]
A completed clinical trial investigating how mental practice affects motor learning in brushing tasks for people with Parkinson's disease; s…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037) [Phase 3]
Phase 3 trial of preladenant in moderate to severe Parkinson's disease completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
This clinical trial update reports the ADAGIO follow-up study, evaluating the long-term effects of rasagiline in subjects with Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinson's Disease [NA]
The clinical trial investigating acupuncture as adjuvant therapy for sleep disorders in Parkinson disease has completed.
-
CLINICAL_TRIALS withdrawal · 2016-04-06Clinical Trial Update: Natural History of Levodopa-Induced Dyskinesia (LID)
The clinical trial studying the natural history of levodopa-induced dyskinesia in Parkinson's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease [Phase 2]
Phase 2 trial evaluating the neuro-protective effect of granulocyte colony-stimulating factor in early Parkinson disease was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch [Phase 1]
A Phase 1 study evaluated the irritation and skin sensitization potential of repeat applications of the rotigotine transdermal patch; the tr…
-
CLINICAL_TRIALS research · 2016-03-31Clinical Trial Update: Parkinson's Disease, Diagnostic Observations (PADDO)
This entry provides a clinical trial update for PADDO, a study focused on diagnostic observations in Parkinson's disease. It also encompasse…